According to PDS Biotechnology 's latest financial reports the company's current earnings (TTM) are -$44.35 M. In 2022 the company made an earning of -$42.06 M a decrease over its 2021 earnings that were of -$21.44 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$44.35 M | 5.46% |
2022 | -$42.06 M | 96.19% |
2021 | -$21.44 M | 44.37% |
2020 | -$14.85 M | 101.18% |
2019 | -$7.39 M | -6.39% |
2018 | -$7.89 M | -85.25% |
2017 | -$53.45 M | 31.42% |
2016 | -$40.67 M | 39.34% |
2015 | -$29.19 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 149.80% | ๐บ๐ธ USA |